Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.

[1]  W. Catalona,et al.  Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: conversion to negative with testosterone administration. , 1979, The Journal of urology.

[2]  Whitmore Wf,et al.  Clinical significance of biologic markers: Memorial Hospital experience. , 1979 .

[3]  S. Loening,et al.  Serum markers in testicular tumors. , 1979, The Journal of urology.

[4]  N. Javadpour,et al.  The National Cancer Institute experience with testicular cancer. , 1978, The Journal of urology.

[5]  R. Wittes,et al.  The evolution of mature teratoma from malignant testicular tumors , 1977, Cancer.

[6]  H. D. Cox,et al.  The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis. , 1977, The Journal of urology.

[7]  T. Waldmann,et al.  Cellular localization of alpha‐fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using an indirect immunoperoxidase technique. A new approach to classification utilizing tumor markers , 1977 .

[8]  Lange Ph,et al.  Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors. , 1977 .

[9]  T. Waldmann,et al.  Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors. , 1977, The Journal of urology.

[10]  D. Johnson,et al.  Metastases from testicular carcinoma. Study of 78 autopsied cases. , 1976, Urology.

[11]  O. Bodansky.  14 – Neoplasms of the Testis , 1975 .

[12]  T. Waldmann,et al.  The use of a radioimmunoassay for alpha‐fetoprotein in the diagnosis of malignancy , 1974, Cancer.